PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Uncovering the genetic causes of bipolar disorder could lead to new treatments

2011-10-25
(Press-News.org) Researchers at the University of Leeds investigating the genetic causes of bipolar disorder have identified two new drugs – one of which has already been found safe in clinical trials – that may be effective in treating the disorder.

Bipolar disorder is characterised by mood swings between mania and depression. Like autism, it is thought to be a spectrum of disorders and, although its causes are not well understood, it seems to run in families and is thought to be caused by both genetic and environmental factors.

Dr Steve Clapcote, of the Institute of Membrane and Systems Biology at the University of Leeds, who led the study, says: "We suspected from published studies of bipolar patients that levels of enzymes known as NKA or sodium pumps may be abnormal in bipolar disorder, but so far the evidence has not been convincing enough to warrant detailed clinical investigations."

The research, published today in the US journal Proceedings of the National Academy of Sciences (PNAS), used a strain of genetically modified mice that exhibit symptoms very similar to humans in the manic phase of the disorder.

The mice were bred with a particular mutation that prevents the NKA enzyme from functioning normally. When tested, the mice showed characteristics closely associated with bipolar disorder, such as increased tendency to take risks, hyperactivity, and disturbed sleep patterns. They also exhibited reduced mania when treated with anti-manic drugs.

Current drugs available to treat bipolar disorders, although usually successful, are limited to either Lithium or Valproate. They can't be matched to specific types of bipolar disorder, and can sometimes cause unpleasant side effects. There is therefore a need for treatments which can be better targeted, and which are more effective and better tolerated by patients.

The Leeds researchers found that the mice showed decreased activity of the NKA enzyme, as well as increased activity of a protein called ERK. Drugs known to have an effect on these two elements were administered to the mice, including Rostafuroxin and SL327, and both reduced their mania-like behaviour.

"Rostafuroxin has been found to be safe in clinical trials for treating high blood pressure," explained Dr Clapcote. "No one has previously looked at this drug's effects on the brain, but our mouse studies show there's a possibility that it might also be suitable for people with mania. Similarly, SL327, which is known to inhibit ERK activity, was also found to reduce manic behaviour in the mice."

"We think there is enough evidence now to start screening people with bipolar disorder to look for genetic mutations in the same NKA enzyme as that affected in our mice," says Dr Clapcote. "This will help us identify whether there is a group of bipolar patients that may be responsive to the novel treatments we have tested in the mice."

He added, "We also want to do some further studies of these drugs on the mice, such as test different doses to see whether there are any side effects, and determine what biochemical changes occur in the drug-treated mice to find out how the drugs work. This will help us determine whether they might be suitable for people."

Dr Tariq Mahmood, a consultant psychiatrist with Leeds Partnerships NHS Foundation Trust, who runs a bipolar disorders clinic, said: "Bipolar disorder is a serious condition that can affect one in 100 people. Like most psychiatric conditions, its biological basis is not well understood, which has hindered our efforts to develop diagnostic tests and specific treatments. This research is exciting and will, hopefully, lead to development of tests that will enable us to diagnose this condition early, and discovery of new drugs that are specific for individual bipolar patients."

INFORMATION:

The research was a collaboration with scientists at the University of Toronto, and was funded by the Canadian Institutes of Health Research and the Medical Research Council.

END



ELSE PRESS RELEASES FROM THIS DATE:

High fizzy soft drink consumption linked to violence among teens

2011-10-25
Teens who drink more than five cans of non-diet, fizzy soft drinks every week are significantly more likely to behave aggressively, suggests research published online in Injury Prevention. This includes carrying a weapon and perpetrating violence against peers and siblings. US lawyers have successfully argued in the past that a defendant accused of murder had diminished capacity as a result of switching to a junk food diet, a legal precedent that subsequently became known as the "Twinkie Defense" – a twinkie being a packaged snack cake with a creamy filling. The researchers ...

Langham Hospitality Group and LRA Worldwide Develop Guest Experience Assessment Program

2011-10-25
Langham Hospitality Group has built its portfolio on its historical and luxurious past - its "Birth of a Legend" branding message evokes the very first Langham that was the talk of Victorian London as Europe's first grand hotel in 1865. Now Langham has partnered with LRA Worldwide, Inc., to evaluate how well Langham associates connect the guest emotionally with its legendary past, using LRA's proprietary Emotional Audit framework. LRA has customized the Emotional Audit protocol to reflect Langham's unique service components and the desired emotional connection ...

Doctors happily cite alcohol as cause of death, but not smoking, for fear of stigmatization

2011-10-25
UK doctors are willing to cite alcohol as a cause of death on death certificates, but not smoking, for fear of stigmatising the deceased, shows research published online in the Journal of Clinical Pathology. This has implications for the true extent of the impact of smoking on health, say the researchers, who point out that the current statistical estimates of the death toll from smoking are potentially flawed. They looked at just over 2,000 death certificates and 236 post mortem reports, issued at a large London teaching hospital between 2003 and 2009, to see what ...

Ancient cooking pots reveal gradual transition to agriculture

Ancient cooking pots reveal gradual transition to agriculture
2011-10-25
Humans may have undergone a gradual rather than an abrupt transition from fishing, hunting and gathering to farming, according to a new study of ancient pottery. Researchers at the University of York and the University of Bradford analysed cooking residues preserved in 133 ceramic vessels from the Western Baltic regions of Northern Europe to establish whether these residues were from terrestrial, marine or freshwater organisms. The research led by Oliver Craig (York) and Carl Heron (Bradford) included an international team of archaeologists from The Heritage Agency ...

b-pack Announces Rehmann deploys b-pack Cloud Purchase-to-Pay solution to control its Procurement

2011-10-25
b-pack announces Rehmann recently chooses b-pack's Purchase-to-Pay Solution to implement their new Procurement and Asset Management strategy. The main objective is to quickly set up these functions with an Innovative On Demand solution. One of the critical imperative of Rehmann was to bring visibility to their purchasing processes and also control their costs more efficiently. Selected in October 2011, b-pack was the best Purchase-to-Pay solution provider to implement Rehmann's new Procurement and Asset Management strategy. Using b-pack, Rehmann is now able to track ...

Study offers clues as to why some patients get infections from cardiac implants

Study offers clues as to why some patients get infections from cardiac implants
2011-10-25
COLUMBUS, Ohio – New research suggests that some patients develop a potentially deadly blood infection from their implanted cardiac devices because bacterial cells in their bodies have gene mutations that allow them to stick to the devices. Patients with implants can develop infections because of a biofilm of persistent bacterial bugs on the surfaces of their devices. Researchers found that some strains of the bacteria, Staphylococcus aureus, have just a few genetic variants in the proteins on their surfaces that make them more likely to form these biofilms. The research ...

With Employee-Wellness Programs and Green Initiatives, U.S. Chemicals Uses a Different Method for Chemical Distribution

2011-10-25
US Chemicals isn't your typical multi-million dollar chemical corporation. From a staff that's made up of roughly 80 percent women to corporate nutritionists to entryway waterfalls, the Darien, Conn. based company is really one-of-a-kind. CEO Carol Piccaro, daughter of founder Howard T. Von Oehsen, wouldn't have it any other way. "Corporate wellness is really important to me," Picarro explains. "Stress can kill you. We've tried to develop a different type of workplace here, and I think it really has a lot to do with wellness and performance and all ...

With Graeme Blackman Leading the Way, Inter-Marine Looks to Build its Own Name from the Renowned Inter-Chillers HVACR Brand

2011-10-25
Originally founded as Blackman Field Services in 1989, Inter-Chillers has since seen its name change, but its commitment to excellence in the field of Heating, Ventilation, Air Conditioning and Refrigeration (HVACR) continues to prosper throughout the reaches of Australia. Based in Sydney and with an office in Melbourne, the company has extensive experience in the HVACR field, with over 800 years of accumulated knowledge in the industry. Graeme Blackman founded the company on the values of hard work and dedicated customer service, and those sentiments are clearly seen ...

Take your blood pressure meds before bed

2011-10-25
Patients who take at least one blood pressure-lowering medication at bedtime have better control of their blood pressure and are less likely to experience heart problems than patients who take medications in the morning Sleep-time blood pressure is a better measure of heart health than wake-time blood pressure About one out of three U.S. adults has high blood pressure Washington, DC (Monday, October 24, 2011) — It's better to take blood pressure-lowering medications before bed rather than first thing in the morning, according to a study appearing in an upcoming issue ...

Patients who don't follow treatments hurt dialysis clinics' pay

2011-10-25
Patient characteristics affect whether dialysis clinics achieve treatment success and receive Medicare reimbursement How well kidney disease patients follow their prescribed treatments has the greatest impact Dialysis clinics in low-income urban areas provide care to more patients who don't follow their prescribed treatments; these clinics get unfairly penalized Washington, DC (Monday, October 24, 2011) — Dialysis clinics that provide care to kidney disease patients who cannot or will not follow their prescribed treatments will be penalized under a new Medicare payment ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Uncovering the genetic causes of bipolar disorder could lead to new treatments